Table 1 Univariable Cox regression analyses for survival in patients with gastric cancer.

From: Development of web-based dynamic nomogram to predict survival in patients with gastric cancer: a population-based study

 

Status

β

HR(CI)

P value

Censored

Dead

Survival time (month), median (IQR)

10.8 (2.9–21.8)

10.0 (5.3–16.7)

 

Age, mean (SD)

61.0 (12.45)

60.3 (13.26)

0.01

1.01 (1.005, 1.02)

0.003

Sex

Male

318 (60.9)

204 (39.1)

0.02

1.02 (0.79, 1.32)

0.877

Female

132 (62.6)

79 (37.4)

Ref*

Ref

Marital status

Married

441 (61.3)

278 (38.7)

0.30

1.35 (0.37, 4.89)

0.543

Single

8 (80.8)

2 (20.0)

Ref

Ref

Smoking

Never used

285 (63.6)

165 (36.7)

Ref

Ref

0.272

Previous or current user

143 (57.0)

108 (43.0)

0.13

1.14 (0.90, 1.45)

BMI

 ≤ 18.5

49 (46.7)

56 (53.3)

0.28

1.33 (0.96, 1.84)

0.082

18.5–25

192 (63.6)

110 (36.4)

Ref

Ref

 

25–30

48 (80.0)

12 (20.0)

−0.48

0.61 (0.34, 1.12)

0.114

 ≥ 30

8 (72.7)

3 (27.3)

−0.46

0.62 (0.19, 1.97)

0.426

Family history

No

314 (61.0)

201 (39.0)

Ref

Ref

0.152

Yes

108 (62.1)

66 (37.9)

−0.19

0.82 (0.62, 1.07)

Type of treatment

Surgery treatment

288 (64.4)

159 (35.6)

Ref

Ref

 

Other treatments

162 (56.6)

124 (43.4)

0.47

1.61 (1.27, 2.04)

 < 0.001

Tumour grade

Well

76 (68.5)

35 (31.5)

Ref

Ref

 

Moderately

89 (65.0)

48 (35.0)

0.17

1.19 (0.77, 1.85)

0.423

Poorly

120 (60.0)

80 (40.0)

0.36

1.44 (0.97, 2.14)

0.072

Undifferentiated

165 (57.9)

120 (42.1)

0.36

1.43 (0.98, 2.09)

0.061

Depth of tumour

T1

13 (81.3)

3 (18.8)

−0.98

0.37 (0.12, 1.12)

0.078

T2

55 (80.9)

13 (19.1)

−1.08

0.33 (0.19, 0.57)

 < 0.001

T3

175 (68.1)

82 (31.9)

−0.46

0.62 (0.48, 0.81)

 < 0.001

T4

90 (41.9)

125 (58.1)

Ref

Ref

 

Number of involved lymph node

N1

86 (66.7)

43 (33.3)

Ref

Ref

 

N2

159 (62.4)

96 (37.6)

0.10

1.11 (0.74, 1.66)

0.582

N3

44 (68.8)

20 (31.3)

0.02

1.02 (0.63, 1.66)

0.914

  1. *Ref: Reference.